|Title||STAT signaling in polycystic kidney disease.|
|Publication Type||Journal Article|
|Year of Publication||2020|
|Authors||Strubl, S, Torres, JA, Spindt, AK, Pellegrini, H, Liebau, MC, Weimbs, T|
|Date Published||2020 Apr 20|
The most common form of polycystic kidney disease (PKD) in humans is caused by mutations in the PKD1 gene coding for polycystin1 (PC1). Among the many identified or proposed functions of PC1 is its ability to regulate the activity of transcription factors of the STAT family. Most STAT proteins that have been investigated were found to be aberrantly activated in kidneys in PKD, and some have been shown to be drivers of disease progression. In this review, we focus on the role of signal transducer and activator of transcription (STAT) signaling pathways in various renal cell types in healthy kidneys as compared to polycystic kidneys, on the mechanisms of STAT regulation by PC1 and other factors, and on the possibility to target STAT signaling for PKD therapy.
|Alternate Journal||Cell. Signal.|